Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast cancer
Oral paclitaxel yields better outcomes than IV paclitaxel in metastatic breast cancer
Novel therapeutic approaches in B-progenitor ALL
Identifying cancer susceptibility genes in paediatric ALL
Defining high-risk acute lymphoblastic leukaemia
Safe staffing and patient outcomes
Discussing the treatment of head and neck tumours in India
How can clinical trial units and networks help deliver high quality cancer trials
Are remissions for AML patients 'better' after daunorubicin and cytarabine liposome injection
Dasatinib vs imatinib in the treatment of paediatric ALL
Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients
PET-Directed therapy for early-stage diffuse large B-cell lymphoma
Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humans